“The MSPrecise CSF assay, along with our LymPro Test blood diagnostic for Alzheimer’s disease, are the two key assets in our diagnostics division,” Gerald E. Commissiong, president and CEO of Amarantus, has frequently stated. “Together, MSPrecise and LymPro will allow Amarantus Diagnostics to very rapidly achieve critical mass as one of the premier neurodiagnostic testing companies in the world.”
Lympro is dead. All this time no one has shown any interest in it. GC is either oblivious to this or in denial. With Lympro being unwanted any sale of the DX division with it a part of will be deeply discounted.